Human Papillomavirus Type–Specific 18-Month Risk of High-Grade Cervical Intraepithelial Neoplasia in Women with a Normal or Borderline/Mildly Dyskaryotic Smear

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Cancer Epidemiology, Biomarkers and Prevention

• Publication date

  2006-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1158/1055-9965.EPI-05-0764PMID 16835322
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice.

  2005influential reference
• Prevalence of types 16 and 33 is increased in high‐risk human papillomavirus positive women with cervical intraepithelial neoplasia grade 2 or worse

  2005cited by this paper
• Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities.

  2005influential reference
• Cancer Epidemiol Biomarkers Prev

  2004cited by this paper
• The Dutch CISOE-A framework for cytology reporting increases efficacy of screening upon standardisation since 1996

  2004cited by this paper
• Against which human papillomavirus types shall we vaccinate and screen? the international perspective

  2004influential reference
• Colposcopically directed biopsy, random cervical biopsy, and endocervical curettage in the diagnosis of cervical intraepithelial neoplasia II or worse.

  2004influential reference
• POBASCAM, a population‐based randomized controlled trial for implementation of high‐risk HPV testing in cervical screening: Design, methods and baseline data of 44,102 women

  2004cited by this paper
• Epidemiologic classification of human papillomavirus types associated with cervical cancer.

  2003cited by this paper
• Inclusion of HPV testing in routine cervical cancer screening for women above 29 years in Germany: results for 8466 patients

  2003influential reference
• Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis

  2003influential reference
• Management of women who test positive for high-risk types of human papillomavirus: the HART study.

  2003influential reference
• Human papillomavirus type 18 and rapidly progressing cervical intraepithelial neoplasia.

  2003influential reference
• Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance.

  2003cited by this paper
• Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.

  2003influential reference
• GP5+/6+ PCR followed by Reverse Line Blot Analysis Enables Rapid and High-Throughput Identification of Human Papillomavirus Genotypes

  2002cited by this paper
• Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women

  2001influential reference
• Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

  1999cited by this paper
• Permutational distribution of the log-rank statistic under random censorship with applications to carcinogenicity assays.

  1998influential reference
• Accurate Bootstrap Confidence Limits for the Cumulative Hazard and Survivor Functions under Random Censoring

  1997influential reference
• A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings

  1997cited by this paper
• PCR‐based high‐risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears

  1996cited by this paper
• Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group.

  1995influential reference
• Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective

  1995cited by this paper
• Cancer epidemiology biomarkers & prevention

  1991cited by this paper

• Prevalence of higher-grade dysplasia in persistently high-risk human papillomavirus positive, cytology negative women after introduction of the new cervical cancer screening in Germany

  2023cites this paper
• Detection of high-grade cervical neoplasia using extended genotyping: Performance data from the longitudinal phase of the Onclarity trial.

  2023cites this paper
• Cost-Effectiveness and Budget Impact Analysis of Primary Screening With Human Papillomavirus Test With Genotyping in Argentina.

  2021cites this paper
• Stratified risk of high-grade cervical disease using onclarity HPV extended genotyping in women, ≥25 years of age, with NILM cytology.

  2019cites this paper
• Clinical Utility of Human Papillomavirus Genotyping in Cervical Cancer Screening: A Systematic Review

  2019cites this paper
• Normal Cytology Results Who Develop Grade 3 Cervical Intraepithelial Neoplasia

  2019cites this paper
• High‐risk papillomavirus infection among women living with human Immunodeficiency virus: Brazilian multicentric study

  2017cites this paper
• The budget impact of cervical cancer screening using HPV primary screening.

  2016cites this paper
• Long‐term risk of cervical intraepithelial neoplasia grade 3 or worse according to high‐risk human papillomavirus genotype and semi‐quantitative viral load among 33,288 women with normal cervical cytology

  2015cites this paper
• Matching intended use and type of HPV test in research and clinical practice

  2015cites this paper
• Clinical Validation of the HPV-Risk Assay, a Novel Real-Time PCR Assay for Detection of High-Risk Human Papillomavirus DNA by Targeting the E7 Region

  2014cites this paper
• New approaches for the diagnosis of human papillomavirus infection:relevance for clinical practice and cancer prevention

  2014cites this paper
• THE NEW ERA OF PRIMARY HPV SCREENING FOR PREVENTION OF INVASIVE CERVICAL CANCER

  2014cites this paper
• Worldwide incidence of cervical lesions: a systematic review

  2014influential citation
• Comparison of Seegene Anyplex II HPV28 with the PGMY-CHUV Assay for Human Papillomavirus Genotyping

  2013cites this paper
• Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions.

  2013cites this paper
• Human papillomavirus prevalence and type in liquid-based Human papillomavirus prevalence and type in liquid-based cervical samples from Turkish women in a selected risk group cervical samples from Turkish women in a selected risk group

  2013cites this paper
• Differential In Vitro Immortalization Capacity of Eleven, Probable High-Risk Human Papillomavirus Types

  2013cites this paper
• hr-HPV testing in the follow-up of women with cytological abnormalities and negative colposcopy

  2013cites this paper
• HPV-based Tests for Cervical Cancer Screening and Management of Cervical Disease

  2013cites this paper
• Clinical progression of high-grade cervical intraepithelial neoplasia: estimating the time to preclinical cervical cancer from doubly censored national registry data.

  2013cites this paper
• Practice of Epidemiology Clinical Progression of High-Grade Cervical Intraepithelial Neoplasia: Estimating the Time to Preclinical Cervical Cancer FromDoubly Censored National Registry Data

  2013cites this paper
• Cost-effectiveness of cervical cancer prevention in Central and Eastern Europe and Central Asia.

  2013cites this paper
• Agreement between colposcopic impression and histological diagnosis among human papillomavirus type 16‐positive women: a clinical trial using dynamic spectral imaging colposcopy

  2012cites this paper
• Long-term CIN3+ risk in women with abnormal cytology; role of hrHPV testing

  2012cites this paper
• Inference of Type-Specific HPV Transmissibility, Progression and Clearance Rates: A Mathematical Modelling Approach

  2012influential citation
• Detection of premalignant cervical lesions: the role of digital colposcopy, human papillomaviruses and biomarkers

  2012cites this paper
• Papanicolaou's nebular cells are related to HPV infection and HSIL

  2012cites this paper
• Development of a Bead-Based Multiplex Genotyping Method for Diagnostic Characterization of HPV Infection

  2012cites this paper
• High-Risk Human Papillomavirus (hrHPV) E6/E7 mRNA Testing by PreTect HPV-Proofer for Detection of Cervical High-Grade Intraepithelial Neoplasia and Cancer among hrHPV DNA-Positive Women with Normal Cytology

  2012cites this paper
• Human papillomavirus genotyping as a predictor of high‐grade cervical dysplasia in women with mildly cytologic abnormalities: A two‐year follow‐up report

  2012cites this paper
• New technologies and procedures for cervical cancer screening.

  2012cites this paper
• Assessment of clinical and analytical performance characteristics of an HPV genotyping test

  2012cites this paper
• HPV type-related chromosomal profiles in high-grade cervical intraepithelial neoplasia

  2012cites this paper
• A pilot analytic study of a research-level, lower-cost human papillomavirus 16, 18, and 45 test.

  2011cites this paper
• Combined Promoter Methylation Analysis of CADM1 and MAL: An Objective Triage Tool for High-Risk Human Papillomavirus DNA–Positive Women

  2011cites this paper
• Genotyping of human papillomavirus in triaging of low-grade cervical cytology.

  2011cites this paper
• Universal human papillomavirus genotyping by the digene HPV Genotyping RH and LQ Tests.

  2011cites this paper
• Sex-Specific Immunization for Sexually Transmitted Infections Such as Human Papillomavirus: Insights from Mathematical Models

  2011cites this paper
• Validation of a Low-Cost Human Papillomavirus Genotyping Assay Based on PGMY PCR and Reverse Blotting Hybridization with Reusable Membranes

  2011cites this paper
• Promoter methylation analysis of WNT/β-catenin signaling pathway regulators to detect adenocarcinoma or its precursor lesion of the cervix.

  2011cites this paper
• Human papillomavirus testing and genotyping in cervical screening

  2011cites this paper
• Running title: Methylation markers to triage hrHPV-positive women

  2011cites this paper
• Long-term Impact of Human Papillomavirus Vaccination on Infection Rates, Cervical Abnormalities, and Cancer Incidence

  2011cites this paper
• Vaccination against human papillomavirus types 16 and 18: the impact on cervical cancer.

  2010cites this paper
• The health and economic effects of HPV DNA screening in The Netherlands

  2010cites this paper
• Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence.

  2010cites this paper
• Model-based estimation of viral transmissibility and infection-induced resistance from the age-dependent prevalence of infection for 14 high-risk types of human papillomavirus.

  2010cites this paper
• Population-Based Cervical Screening GP 5 + / 6 +-PCR-Enzyme Immunoassay in Detection with That of the PapilloCheck Human Papillomavirus Comparison of the Clinical Performance of

  2010cites this paper
• High‐risk human papillomavirus DNA load in a population‐based cervical screening cohort in relation to the detection of high‐grade cervical intraepithelial neoplasia and cervical cancer

  2009cites this paper
• Factors associated with the risk of progression to precursor lesions or cervical cancer in women with negative cytologic findings

  2009cites this paper
• How to screen for cervical cancer after HPV16/18 vaccination in The Netherlands.

  2009cites this paper
• An update review on HPV testing methods for cervical neoplasia.

  2009cites this paper
• High-throughput genotyping of high-risk HPV by the digene HPV Genotyping LQ Test using GP5+/6+-PCR and xMAP technology.

  2009cites this paper
• High genotyping concordance between the digene HPV Genotyping RH Test and the Reverse Line Blot genotyping assay on GP5+/6+-PCR products.

  2009cites this paper
• Prevention of cervical cancer

  2009cites this paper
• Human papillomavirus genotyping using an automated film-based chip array.

  2009cites this paper
• Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening.

  2009cites this paper
• HPV16/18 vaccination to prevent cervical cancer in The Netherlands: Model‐based cost‐effectiveness

  2009cites this paper
• Comparison of the Clinical Performance of PapilloCheck Human Papillomavirus Detection with That of the GP5+/6+-PCR-Enzyme Immunoassay in Population-Based Cervical Screening

  2009cites this paper
• Prevention of cervical cancer in the Netherlands : Studies on cytology and HPV infections

  2008cites this paper
• Human papillomavirus testing and its application in cervical cancer prevention

  2008cites this paper
• The potential utility of HPV genotyping in screening and clinical management.

  2008cites this paper
• Comparison of GP5+/6+-PCR and SPF10-Line Blot Assays for Detection of High-Risk Human Papillomavirus in Samples from Women with Normal Cytology Results Who Develop Grade 3 Cervical Intraepithelial Neoplasia

  2008cites this paper
• Risk Assessment of Cervical Disease by hrHPV Testing and Cytology

  2008cites this paper
• Primary hrHPV testing in cervical screening: the arguments

  2008cites this paper
• High-risk human papillomavirus testing in cervical screening: which assay?

  2008cites this paper
• High-risk HPV type-specific clearance rates in cervical screening

  2007influential citation
• Targeting the human papillomavirus for prevention of cervical cancer

  2007cites this paper
• Comparison of Linear Array and Line Blot Assay for Detection of Human Papillomavirus and Diagnosis of Cervical Precancer and Cancer in the Atypical Squamous Cell of Undetermined Significance and Low-Grade Squamous Intraepithelial Lesion Triage Study

  2007cites this paper
• Risk Factors for Cervical Cancer Development

  2007cites this paper
• Risk of high‐grade cervical intra‐epithelial neoplasia based on cytology and high‐risk HPV testing at baseline and at 6‐months

  2007cites this paper
• The contribution of HPV18 to cervical cancer is underestimated using high-grade CIN as a measure of screening efficiency

  2007cites this paper
• HPV type-specific risks of high-grade CIN during 4 years of follow-up: A population-based prospective study

  2007cites this paper
• Human papillomavirus prevalence and type in liquid-based cervical samples from Turkish women in a selected risk group

  2007cites this paper
• Department of Medical Epidemiology and Biostatistics,

  2007cites this paper
• Cross-Sectional Comparison of an Automated Hybrid Capture 2 Assay and the Consensus GP5+/6+ PCR Method in a Population-Based Cervical Screening Program

  2006cites this paper
• 2.2 12.2 12.2 12.2 Use of Hpv Tests Use of Hpv Tests Use of Hpv Tests Use of Hpv Tests

  year unknowncites this paper